Engage Technologies Group, which offers a cloud-based patient engagement and education platform, raised $15 million in Series A funding from individual healthcare professionals.
Including the latest funding round, Engage has raised 20 million to date. The company previously raised $5 million in seed funding. Engage plans to use the latest proceeds to enter new markets and create rich video content that aligns the patient journey from diagnosis to recovery.
Founded in 2016, Engage through its four divisions: Aesthetic Innovations, Ocular Innovations, Dental Innovations, and Health Innovations delivers mobile video engagement technologies in multiple healthcare market verticals. Engage’s platforms are specifically designed to optimize the patient journey in partnership with medical practitioners, clinical and administrative staff, and health industry manufacturers, the company said.
“Today’s funding announcement is a significant milestone for the company,” Michael Boerner, CEO, and Founder of Engage.
Michael Boerner added: “Our breakthrough in mobile intelligence storytelling, coupled with the recent capital milestone, enables us to further equip providers with a solution they have always wanted for their patients; a just-in-time, friction-free, anxiety-relieving, journey describing, ‘yellow brick road’ to seamlessly follow.”
“We can finally help physicians, surgeons, and their clinical teams streamline and measure every step across the patient care continuum, without portals, apps, email, and logins. Simple is finally possible, added Michael Boerner.”
Patient engagement companies raised over $1.1 billion in VC funding since 2013, according to Mercom’s digital health funding database.
Recently, Lifelink Systems, an AI-powered patient engagement platform, raised $9.75 million in a Series A funding round, led by DigiTx Partners, and included Primera Capital, Baleon Capital. Insightin Health, an AI-powered patient engagement platform, raised $12 million in a Series A funding round led by Blue Venture Fund and Sandbox with existing investors.